← FDA Drug Approvals (Drugs@FDA)

SITAGLIPTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO., · Approved 2026-01-26

Drug application

FDA Application #

ANDA217041

Application type

Abbreviated New Drug Application (Generic)

Brand name

SITAGLIPTIN

Generic name

Sitagliptin Phosphate

Active ingredients

SITAGLIPTIN PHOSPHATE

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

FOSUN WANBANG (JIANGSU) PHARMACEUTICAL GROUP CO.,

First approval

2026-01-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown